North America Transdermal Drug Delivery System Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Type (Transdermal Patches, Transdermal Gel, Transdermal Sprays, and Others), Application (Cardiovascular Diseases, Central Nervous System Disorders, Pain Management, Hormonal Applications, and Other Applications), and Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)

No. of Pages: 109
Report Code: TIPRE00013277
Category: Life Sciences
North America Transdermal Drug Delivery System Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. North America Transdermal Drug Delivery System Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. North America Transdermal Drug Delivery System Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. North America Transdermal Drug Delivery System Market Regional Analysis

6.2 North America Transdermal Drug Delivery System Market Revenue 2020-2030 (US$ Million)
6.3 North America Transdermal Drug Delivery System Market Forecast Analysis

7. North America Transdermal Drug Delivery System Market Analysis – by Type

7.1 Transdermal Patches
  • 7.1.1 Overview
  • 7.1.2 Transdermal Patches: North America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Transdermal Gel
  • 7.2.1 Overview
  • 7.2.2 Transdermal Gel: North America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Transdermal Sprays
  • 7.3.1 Overview
  • 7.3.2 Transdermal Sprays: North America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America Transdermal Drug Delivery System Market Analysis – by Application

8.1 Cardiovascular Diseases
  • 8.1.1 Overview
  • 8.1.2 Cardiovascular Diseases: North America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Central Nervous System Disorders
  • 8.2.1 Overview
  • 8.2.2 Central Nervous System Disorders: North America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Pain Management
  • 8.3.1 Overview
  • 8.3.2 Pain Management: North America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Hormonal Applications
  • 8.4.1 Overview
  • 8.4.2 Hormonal Applications: North America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Other Applications
  • 8.5.1 Overview
  • 8.5.2 Other Applications: North America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America Transdermal Drug Delivery System Market Analysis – by Distribution Channel

9.1 Hospitals Pharmacies
  • 9.1.1 Overview
  • 9.1.2 Hospitals Pharmacies: North America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Retail Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Retail Pharmacies: North America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Online Pharmacies
  • 9.3.1 Overview
  • 9.3.2 Online Pharmacies: North America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. North America Transdermal Drug Delivery System Market – North America Analysis

10.1 Overview

10.2 North America
  • 10.2.1 North America Transdermal Drug Delivery System Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.2.1.1 North America Transdermal Drug Delivery System Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 US: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.1.1 US: North America Transdermal Drug Delivery System Market Breakdown, by Type
    • 10.2.1.1.2 US: North America Transdermal Drug Delivery System Market Breakdown, by Application
    • 10.2.1.1.3 US: North America Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
  • 10.2.1.2 Canada: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.2.1 Canada: North America Transdermal Drug Delivery System Market Breakdown, by Type
    • 10.2.1.2.2 Canada: North America Transdermal Drug Delivery System Market Breakdown, by Application
    • 10.2.1.2.3 Canada: North America Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
  • 10.2.1.3 Mexico : North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.3.1 Mexico : North America Transdermal Drug Delivery System Market Breakdown, by Type
    • 10.2.1.3.2 Mexico : North America Transdermal Drug Delivery System Market Breakdown, by Application
    • 10.2.1.3.3 Mexico : North America Transdermal Drug Delivery System Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Boehringer Ingelheim International GmbH
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 GSK Plc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Hisamitsu Pharmaceutical Co Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Johnson & Johnson
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Lavipharm SA
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Luye Pharma Group Ltd
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Novartis AG
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Purdue Pharma LP
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 UCB SA
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Viatris Inc
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - North America Transdermal Drug Delivery System Market

  • Boehringer Ingelheim International GmbH
  • GSK Plc
  • Hisamitsu Pharmaceutical Co Inc
  • Johnson & Johnson
  • Lavipharm SA
  • Luye Pharma Group Ltd
  • Novartis AG
  • Purdue Pharma LP
  • UCB SA
  • Viatris Inc
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)